Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Wes Stevens who wrote (951)	9/2/1999 5:17:00 PM
From: Jim	Read Replies (1) \| Respond to of 2515

I had heard AHP or ABT was at IMCL about 2mo ago. I will confirm who it was latter. I know this because a employee told me so. Most physicians in the field feel IMCL is in cake walk to fda fast track approval. Iknow Dr. Waksal feels the same way!!! "'We've been offered a lot of firm deals,'' Waksal said in an interview. ''There's no amount of money that somebody could pay us right now that would give us the value for shareholders that we could get if we launched this drug. What we do after that is up for discussion.'' Untill then hold on for "100" [imo]